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The bipotential gonad expresses genes associated with both the male and female pathways. Adoption of
the male testicular fate is associated with the repression of many female genes including Wnt4.
However, the importance of repression of Wnt4 to the establishment of male development was not
previously determined. Deletion of either Fgf9 or Fgfr2 in an XY gonad resulted in up-regulation ofWnt4
and male-to-female sex reversal. We investigated whether the deletion if Wnt4 could rescue sex
reversal in Fgf9 and Fgfr2 mutants. XY Fgf9/Wnt4 and Fgfr2/Wnt4 double mutants developed testes with
male somatic and germ cells present, suggesting that the primary role of Fgf signaling is the repression
of female-promoting genes. Thus, the decision to adopt the male fate is based not only on whether male
genes, such as Sox9, are expressed, but also on the active repression of female genes, such as Wnt4.
Because loss of Wnt4 results in the up-regulation of Fgf9, we also tested the possibility that
derepression of Fgf9 was responsible for the aspects of male development observed in XX Wnt4
mutants. However, we found that the relationship between these two signaling factors is not
symmetric: loss of Fgf9 in XX Wnt4/ gonads does not rescue their partial female-to-male sex-
reversal.
& 2012 Elsevier Inc. All rights reserved.Introduction
The mammalian gonad forms initially as a bipotential primor-
dium that is capable of developing into either a testis or ovary.
The fate of a population of somatic cells called the supporting
cells controls sex determination by either giving rise to Sertoli
cells of the testis or a population of granulosa cells in the ovary.
Prior to sex determination, supporting cells in XX and XY gonads
have an identical expression proﬁle. They express genes later
associated with both the male and female pathways, although
they show a bias toward the female pathway at the undiffer-
entiated stage (Jameson et al., 2012).
In mammals, the adoption of the male fate is determined by
the expression of the sex-determining gene from the Y-chromo-
some, Sry (sex determining region of Chr Y) in supporting cell
precursors. Expression of Sry up-regulates Sox9 (Sry-box contain-
ing gene 9), and initiates Sertoli cell differentiation and testis
development (Gubbay et al., 1990; Koopman et al., 1991; Sekido
et al., 2004; Sekido and Lovell-Badge, 2008). Sox9 is critical for
testis development (Bishop et al., 2000; Chaboissier et al., 2004;
Huang et al., 1999; Vidal et al., 2001; Wagner et al., 1994), but
other genes are also required, such as Fgf9 and its receptor Fgfr2.
Deletion of Fgf9 (ﬁbroblast growth factor 9) or Fgfr2 (ﬁbroblastll rights reserved.growth factor receptor 2) results in male-to-female sex reversal
(Bagheri-Fam et al., 2008; Colvin et al., 2001; Kim et al., 2007).
A robust transcriptional repression program characterizes the
commitment of the supporting cells to the Sertoli fate (Jameson
et al., 2012). Many female-associated genes (including Wnt4,
wingless-related MMTV integration site 4) are initially expressed
in the sexually undifferentiated supporting cells, and are
repressed during male development (Jameson et al., 2012; Nef
et al., 2005; Vainio et al., 1999). Exogenous FGF9 can repressWnt4
expression in cultured gonads (Kim et al., 2006), suggesting it is a
mediator of female gene repression. Consistent with this result, in
the absence of Fgf9, (Fgf9 /), Wnt4 was up-regulated in XY
gonads by E12.5. However, Fgf9 / gonads also showed loss of
Sox9 expression and full male-to-female sex reversal (Kim et al.,
2006). Based on these ﬁndings, we proposed that Fgf9 and Sox9
act in a feed-forward loop to reinforce SOX9 expression and
repress Wnt4 (Kim et al., 2006). However, within this general
model, the primary cause of sex reversal was not determined.
There is reciprocal evidence that Wnt4 acts as an antagonist of
the male pathway. Stabilization of the Wnt4 downstream target
b-catenin in XY gonads leads to silencing of SOX9 and the male
pathway (Maatouk et al., 2008). XX gonads mutant for the Wnt
signaling components Wnt4, Rspo1 (R-spondin homolog), or
Ctnnb1 (b-catenin) show partial female-to-male sex reversal.
Fgf9 is expressed in XX Wnt4 mutants, endothelial cells migrate
into the XX gonad and form male-type vasculature, and XX cells
express steroidogenic enzymes characteristic of the testis,
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development of the gonad (Chassot et al., 2008; Jeays-Ward
et al., 2003; Kim et al., 2006; Liu et al., 2009; Manuylov et al.,
2008; Tomizuka et al., 2008; Vainio et al., 1999). Although
constitutively active b-catenin can block male development of
XY gonads, the importance of repression of the normal female
program to Sertoli cell differentiation and testis development was
not clear.
One open possibility was that Fgf9 signaling is primarily
required to block Wnt4 and the female pathway rather than to
activate Sox9 and male development. To test this possibility, we
generated XY mice mutant for both Wnt4 and Fgf9 or its receptor
Fgfr2. If the primary role of Fgf9 is to activate the male pathway,
double mutants should be female. However, if the primary role of
Fgf9 is to repress Wnt4 and the female pathway, these mice
should be male.
In both sets of double mutants, the additional deletion ofWnt4
rescued the XY Fgf9 and Fgfr2 male-to-female sex reversal
phenotypes in somatic and germ cells. This indicates that the
repression of Wnt4 is required for male development. On the
other hand, we found that the phenotype of the XXWnt4mutants
was not rescued by deleting Fgf9, indicating that the partial male
sex reversal in XX gonads does not depend on the up-regulation
of Fgf9. Thus, Fgf signaling is required to repress female genes
during testis development, but it is not required to maintain Sox9,
regulate male germ cell development, or activate male vascular
development and steroidogenesis.Materials and methods
Mice
All animals were maintained and experiments were conducted
according to DUMC-IACUC and NIH guidelines, based on existing
protocols. Fgf9þ / (Colvin et al., 2001) and Wnt4þ / (Stark et al.,
1994) were separately maintained as heterozygotes on the C57BL/
6 strain. For qRT-PCR experiments, Fgf9/ embryos and their
control littermates were generated by intercrossing Fgf9þ / mice.
For more precise staging, tail somites distal to the hindlimb were
counted (Hacker et al., 1995). E11.5 embryos had 16–19 tail
somites, E11.75 embryos had 20–23 tail somites, and E12.5
embryos had 27–28 tail somites. Gonads were dissected away
from the mesonephros prior to RNA extraction. ‘‘Control’’ mice
were Fgf9þ / or Fgf9þ /þ .
Fgf9þ / and Wnt4þ / mice (on the C57BL/6 strain) were
intercrossed to generate Fgf9þ /; Wnt4þ / offspring, which were
intercrossed to generate double mutant embryos. The genotypes and
chromosomal sex of the embryos were determined as previously
described (Colvin et al., 2001; Munger et al., 2009; Stark et al., 1994).
Embryos were isolated between about E16.5 and E17.5. Brightﬁeld
images of the gonads were collected on a Leica MZ12 following the
dissection. ‘‘Control’’ mice were heterozygous or homozygous wild
type at the Fgf9 and Wnt4 loci.
A mixed background Fgfr2ﬂox/ﬂox line (Yu et al., 2003) was
backcrossed two or more generations to C57BL/6, during the
processes of crossing on the Wnt4 null allele (Stark et al., 1994)
and the Sf1-Cre allele (Bingham et al., 2006) that are maintained
on C57BL/6. These mice were intercrossed to generate Fgfr2ﬂox/ﬂox;
Wnt4þ / mice, some of which also had Sf1-Cre, and the line was
maintained by intercrossing to preserve homozygosity at the
Fgfr2 locus. Timed matings were established between fertile Sf1-
Cre; Fgfr2ﬂox/ﬂox; Wnt4þ / males (see Fig. 2 for explanation) and
Fgfr2ﬂox/ﬂox; Wnt4þ / females. Similar methods were also used to
generate mice that carried Flk1-Cre (Motoike et al., 2003) and
Fgfr2ﬂox/þ . Flk1-Cre; Fgfr2ﬂox/þ males were crossed to Fgfr2ﬂox/ﬂoxfemales. E0.5 was deﬁned as noon on the day a mating plug was
detected. Embryos were collected from pregnant females on the
morning of day E13.5. The genotypes (Stark et al., 1994; Yu et al.,
2003) and chromosomal sex (Munger et al., 2009) of the embryos
were determined as previously described. We determined
whether Cre was present using the primers 50-CCAGGGCGC-
GAGTTGATAGC-30 and 50-CTGCCACGACCAAGTGACAGC-30. ‘‘Control’’
mice were all Fgfr2ﬂox/ﬂox, negative for Sf1-Cre, and either Wnt4þ /
or Wnt4þ /þ .
qRT-PCR
Isolated gonads were frozen at 80 1C. RNA was extracted as
previously described (Munger et al., 2009), treated with DNaseI,
and converted to cDNA using the iScript cDNA synthesis kit (170-
8891, Bio-Rad, Hercules, CA). Each cDNA sample was run in
technical triplicate on a StepOnePlus Real-time PCR system
(Applied Biosystems, Carlsbad, CA). The threshold and baseline
were set manually. Generally, the average CT value of the
technical replicates was analyzed using the ‘‘normalized expres-
sion’’ method described previously (Simon, 2003). Canx was used
for normalization (van den Bergen et al., 2009). Since all primer
sets appeared to have greater than 95% efﬁciency (data not
shown), we assumed all primers were perfectly efﬁcient. If the
difference in CT values of technical triplicates exceeded 0.5, the
outlier sample was excluded from the average. If no sample was
an outlier, all replicates were retained so long as the difference
in CT values was less than 0.75. The list of primers is provided
(Table S1), several of which have been previously published
(Manuylov et al., 2008; Munger et al., 2009).
Generally, three individual gonad pairs were analyzed for each
genotype at each stage (three biological replicates). The normal-
ized expression values from the biological replicates were aver-
aged to calculate mean normalized expression (MNE). A signiﬁcant
difference in normalized expression between genotypes was
determined using a T-test. To reduce technical variability in
expression at E11.5 and E11.75, we used qRT-PCR data only when
the reactions for all of the biological replicates were set up at the
same time. Four independent E11.75 XY Fgf9 / samples were
analyzed. For one sample, the Foxl2 reading was eliminated
because the CT value was within 3 cycles of the negative control,
but data from that sample for other genes was retained in the
analysis.
Immunoﬂuorescence
Gonads were immunostained as previously described (Cook
et al., 2009). All E13.5 gonads were stained as whole mounts with
the mesonephros attached. At/after E16.5, phenotypically female
samples (including XY Fgf9/ samples) were stained as whole
mounts after removing mesonephric structures. The whole mount
samples were either immunostained immediately, or processed
through a methanol series and stored at 80 1C prior to rehydra-
tion and immunostaining (Barske and Capel, 2010). Phenotypically
male samples from E16.5 and after were cryosectioned after
removing the mesonephric structures. Since the male and female
samples were processed separately at E16.5–E17.5, we included
CD-1 (Charles River, Wilmington, MA) positive/negative controls in
each batch of immunostained samples (i.e., E13.5 CD-1 male gonads
were stained as whole mounts with the E16.5 female samples, and
E16.5 CD-1 female gonads were cryosectioned and stained with the
E16.5–E17.5 males) (data not shown). E12.5 CD-1 male gonads
were also used as the positive control in Fig. S3 for the Ki67
immunostaining. For the DNMT3L immunostaining (Fig. 5F–J),
cryosectioned XY Fgf9/ samples and CD-1 female controls are
shown because the antibody did not work in whole mount.
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Biotechnology, Santa Cruz, CA) used 1:75 in samples processed
through methanol or KO607 (TransGenic Inc., Kobe, Japan) used at
1:250; anti-AMH (MIS, sc-6886, Santa Cruz Biotechnology) used
at 1:500; anti-CDH1 (13-1900, Invitrogen, Camarillo, CA) initially
reconstituted in 400 ml and used at 1:250; anti-FOXL2 (NB100-
1277, Novus Biologicals, Littleton, CO) used at 1:250; anti-Ki67
(RM-9106-S, Neomarkers, Thermo Scientiﬁc, Waltham, MA) used
at 1:500; anti-NRP1 (AF566, R&D Biosystems, Minneapolis, MN)
used at 1:350; anti-PECAM1 (CD31, 553370, BD Pharmingen, San
Diego, CA) used at 1:250; anti-SCP3 (ab15093, Abcam, Cambridge,
MA) used at 1:500-1:1000; anti-SOX9 (AB5535, Millipore, Bill-
erica, MA) used at 1:3000-1:5000, and anti-DNMT3L (kindly
provided by Dr. Shoji Tajima, Osaka University, Japan) used at
1:125. Secondary antibodies used included Alexa 647- and 488-
conjugated secondary antibodies (Molecular Probes, Grand Island,
NY) used at 1:500, and Cy3-conjugated secondary antibodies
(Jackson ImmunoResearch, West Grove, PA) used at 1:500. DAPI
(Sigma-Aldrich, St. Louis, MO) was used to label nuclei. Samples
were mounted in 2.5% DABCO (Sigma-Aldrich) in 90% glycerol. In
some samples, Hoechst 333420 (Invitrogen, Eugene, OR, USA) was
also used to lable DNA (Fig. 5F–J).
Samples were immunostained at the same time as opposite
sex controls to ensure that all antibodies were working properly.
Samples stained at the same time were also imaged at the same
time on a Leica SP2 confocal microscope. Leica confocal software,
copyright 1997–2004, by Leica Microsystems Heidelberg GmbH
was used to generate maximum intensity projections of multiple
images along the Z axis (Figs. 4–6, S2–S4). In some cases, multipleFig. 1. Wnt4, Rspo1 and Foxl2 transcript levels are indistinguishable from XX gonads, w
data from XY control (cyan), XY Fgf9/ (green), and XX control (magenta) gonads at E1
methods) is shown, using Canx as the normalizing gene. A signiﬁcant difference (as det
black asterisk over the sex with lower expression. A signiﬁcant difference between XY
difference between the XY Fgf9 / and XX control samples is indicated by a magenta
gonads when compared to both XX and XY controls, even though Sox9 protein was l
expression of Sox9 between XY control and Fgf9/ gonads at E11.5 and E11.75, the a
indicating that Fgf9 could play a role in up-regulating Sox9 or fewer Sox9-positive cells m
observed at any time point between the XY Fgf9/ and XX control gonads. While the
E12.5, elevated expression of these female-associated genes was apparent in both the X
loss of Fgf9 resulted in the over-expression of multiple female genes.overlapping images were taken along the Y axis in a single Z
plane, and these were assembled by eye to survey the entire
gonad (Fig. 2, S1 and S5). A Zeiss 710 inverted confocal micro-
scope was used to collect some images as well, and the Zeiss free
ofﬂine software was used to generate maximum intensity projec-
tions (Fig. 5F–J).Results
Gene expression in XY Fgf9 mutants
Previous work demonstrated that exogenous FGF9 could
repress Wnt4, and that Wnt4 expression was elevated in XY
Fgf9 / gonads by E12.5 (Kim et al., 2006). To better characterize
the timing of gene expression changes, we used qRT-PCR at E11.5,
E11.75, and E12.5 to determine the transcriptional regulation of
Sox9 and female genes relative to the loss of SOX9 protein at E12.5
(Kim et al., 2006). We expected some expression variability in
samples collected before E12.5 (Munger et al., 2009), but we were
able to identify distinct trends in the data even when the
differences were not yet signiﬁcant.
At all time points, Sox9 expression was signiﬁcantly higher in
XY Fgf9 / gonads than in XX control gonads (Fig. 1A). At E11.5
and E11.75, Sox9 was not signiﬁcantly different between XY
control and Fgf9 / gonads, but it did appear to be consistently
lower in XY Fgf9 mutant gonads. This difference became signiﬁ-
cant at E12.5. Therefore, we could not exclude the possibility that
Fgf9 has some role in up-regulating Sox9 expression. Nevertheless,hereas Sox9 levels are somewhat lower in XY Fgf9/ gonads. ((A)–(D)) qRT-PCR
1.5, E11.75, and E12.5. n¼3 or 4. Mean normalized expression (as described in the
ermined by a T-test, p-value o0.05) between XX and XY samples is indicated by a
Fgf9/ and XY control samples is indicated by a cyan asterisk, while a signiﬁcant
asterisk. (A) Sox9 was expressed at an intermediate level at E12.5 in XY Fgf9/
ost by this stage (Kim et al., 2006). While there was no signiﬁcant difference in
verage expression of Sox9 in XY Fgf9 mutants was lower than that in XY controls,
ay be present. ((B)–(D)) For female associated genes, no signiﬁcant difference was
differences between XX and XY control gonads were not always signiﬁcant before
X control and XY Fgf9 / gonads when compared to the XY control gonads. Thus,
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even though SOX9 protein was absent at E12.5 (Kim et al., 2006).
This ﬁnding suggested post-transcriptional regulation of SOX9 in
the XY Fgf9 mutants.
We examined the expression of three female associated genes in
XY Fgf9 / gonads: Wnt4, Rspo1, and Foxl2 (Forkhead box L2)
(Chassot et al., 2008; Schmidt et al., 2004; Tomizuka et al., 2008;
Vainio et al., 1999) (Fig. 1B–D). No signiﬁcant differences were
observed between the expression of these genes in the XX control
and XY Fgf9 / gonads at any time point. The expression of these
genes in XY Fgf9 / and XX control gonads appeared different from
XY control gonads by E11.75, although this difference generally was
not signiﬁcant until E12.5. Thus, even though SOX9 protein was
present at this time (Kim et al., 2006), there was an early derepres-
sion of female genes in XY Fgf9 / gonads. This demonstrated that
Fgf9 is required for the repression of multiple female associated
genes early in gonad development in vivo.
The partial sex reversal observed in XY Fgfr2 mutants was rescued by
deleting Wnt4
In previous work, we found that many female genes are actively
repressed during male gonad development (Jameson et al., 2012).
The ﬁnding that multiple female genes were derepressed early in XY
Fgf9 / gonads in vivo (Fig. 1) led us to hypothesize that the
primary cause of the male-to-female sex reversal in both the Fgf9
and Fgfr2 XY mutants (Bagheri-Fam et al., 2008; Colvin et al., 2001;
Kim et al., 2007) was the derepression of the Wnt pathway. If this
were the case, we expected that the deletion of Wnt4 should rescue
the Fgf9 and Fgfr2 XY mutant phenotypes.
We tested this ﬁrst in the Fgfr2 mutants. We used a null allele
of Wnt4 (Stark et al., 1994), and a ﬂoxed allele of Fgfr2 (Yu et al.,
2003) conditionally deleted using the Sf1-Cre transgene (Bingham
et al., 2006). These mice were maintained on a mixed strain
background with a large C57BL/6 contribution, since the sex
reversal phenotype of Fgfr2 mutants is sensitive to strain back-
ground (Bagheri-Fam et al., 2008). Gonads were collected at E13.5Fig. 2. Deleting Wnt4 rescued the partial sex reversal induced by loss of Fgfr2. Immunoﬂuor
blue), SOX9 (red), and FOXL2 (green). XX controls (A) had no testis cords and expresse
Sertoli cells surrounding the germ cells in testis cords with rare FOXL2-positive cells (arr
reversed. Cells at the poles of the gonad (arrows) expressed FOXL2 and cords were absen
positive cells and testis cord structure. ((E) and (F)) Loss of one or two alleles of Wnt4 su
Wnt4 / samples (F), there were testis cords throughout the gonad with SOX9 and few
assembled to span the entire gonad, and placed on a black background. Scale bar¼100and immunostained for FOXL2 (a marker of the female supporting
cell fate) and SOX9 (a marker of the male supporting cell fate)
(Fig. 2A and B), and analyzed for male-speciﬁc vasculature and
the development of testis cord structures enclosing germ cells
(Brennan and Capel, 2004) using PECAM1 to label the germ cells
and the vasculature. Deleting Wnt4 alone did not disrupt general
male development (Fig. 2C), although it was previously observed
that the XY gonad was slightly smaller and had early defects in
gene expression (Jeays-Ward et al., 2004).
XY Sf1-Cre; Fgfr2ﬂox/ﬂox gonads exhibited partial male-to-
female sex reversal, consistent with previous observations
(Bagheri-Fam et al., 2008; Kim et al., 2007) (Fig. 2D). They
expressed substantially more FOXL2 and less SOX9 than XY
controls, and testis cord structures were disrupted at the poles
of the gonad. In XY Sf1-Cre; Fgfr2ﬂox/ﬂox gonads that were hetero-
zygous or homozygous null forWnt4, there was substantial rescue
of the Fgfr2 mutant phenotype (Fig. 2E and F). The rescue
phenotype of XY Sf1-Cre; Fgfr2ﬂox/ﬂox; Wnt4þ / mice was robust
and resulted in fertile males that were used in breeding (Fig. 2E),
indicating that not only somatic, but male germ cell development
occurs normally in double mutants. In the Wnt4 null samples,
SOX9 positive testis cords extended to the poles of the gonad, and
few cells were positive for FOXL2 (Fig. 2F). The rescue of the Fgfr2
mutant phenotype was consistent and clear, despite variability
observed among control samples that could be due to the mixed
strain, minor differences in stage, or natural variability among
individuals at this early stage (Fig. S1). Thus, as hypothesized, the
deletion of Wnt4 rescued the male-to-female sex reversal in the
XY Fgfr2 mutants, consistent with the idea that the derepression
of female genes plays a primary role in the sex reversal in XY Fgfr2
mutants.
Male-to-female sex reversal caused by Fgf9 deletion was rescued by
deleting Wnt4
We also tested whether the deletion of Wnt4 could rescue the
more severe complete male-to-female sex reversal in the XY Fgf9escence of E13.5 gonads stained with PECAM1 (labeling germ cells and vasculature,
d FOXL2. In contrast, XY controls (B) and XY Wnt4 mutants (C) had SOX9-positive
owheads). (D) XY mice with Fgfr2 deleted in the supporting cells were partially sex
t, as in the female control. The center of the gonad was more testicular with SOX9-
bstantially rescued the Fgfr2 phenotype. Particularly in the XY Sf1-Cre; Fgfr2ﬂox/ﬂox;
FOXL2-positive cells (arrowheads). Images were captured using a 40X objective,
mm. nZ3 of each genotype.
Fig. 3. Deleting Wnt4 rescued the sex reversal induced by loss of Fgf9, further supporting the Wnt4 repression model. Brightﬁeld images of E16.5–E17.5 gonads with
mesonephric-derived structures. Control XX ovaries (A) and XY testes (B) had distinct morphologies. Dotted lines surround the ovaries. (C) XY gonads carrying a deletion of
Wnt4 developed as testes, but (D) the deletion of Fgf9 resulted in sex reversal and development of an ovary, even with the deletion of one copy of Wnt4. (E) Deleting both
Wnt4 and Fgf9 rescued testis development. Scale bar¼1 mm. nZ3 of each genotype.
Fig. 4. XY Fgf9/Wnt4 double mutants express molecular markers typical of testis development consistent with a full rescue of sex reversal. Immunostaining of E16.5–E17.5
gonads. DNA is shown in blue. ((A)–(E)) Gonads labeled with the Sertoli-cell markers SOX9 (red) and AMH (green). Sertoli cells labeled with SOX9 and AMH were absent in
XX controls (A), but present in XY controls (B) and XY Wnt4 mutants (C). Similar to XX controls, sex reversed XY Fgf9 mutants (D) lacked differentiating Sertoli cells,
although a variable number of SOX9 positive cells were observed that did not express AMH (arrows). Sertoli cells were rescued by deleting Wnt4 in XY Fgf9 mutants (E).
((F)–(J)) Gonads labeled with the germ cell marker CDH1 (red) and the Leydig cell marker 3b-HSD (green). In the XX control (F), germ cells were present but not clustered
into testis cords and Leydig cells were absent. In the XY control (G) and XY Wnt4 mutant (H), germ cells were clustered into testis cords with Leydig cells positive for 3b-
HSD outside of testis cords. Sex reversed XY Fgf9 mutants (I) resembled XX controls, but deleting Wnt4 in an XY Fgf9 mutant (J) rescued Leydig cells and the presence of
germ cells in testis cords. The arrowhead indicates occasional background staining with the 3b-HSD antibody in the testis cords. Thus, deleting Wnt4 rescued the Fgf9
phenotype in the XY samples based on the detection of molecular markers characteristic of the prominent testicular cell types. All images shown are maximum intensity
projections of 12 images over approximately 12 mm using a 40X objective. For XY Wnt4 ((C) and (H)) and Fgf9 ((D) and (I)) single mutants, the other locus was either
homozygous wild type or heterozygous (designated ‘‘Fgf9þ ’’ and ‘‘Wnt4þ ’’). Scale bars¼100 mm. nZ3 of each genotype.
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collected Fgf9/Wnt4 double mutant samples around E16.5–E17.5
to avoid some of the variability observed at the earlier stage (Fig.
S1) and to assay other roles for Fgf (such as an involvement in
germ cell commitment to the male fate).
XX and XY gonads were visibly distinct at this stage, and the
XY Wnt4 mutant gonads showed clear testicular morphology
(Fig. 3A–C). In contrast, the XY Fgf9 mutants showed full male-to-
female sex reversal (Fig. 3D), consistent with previous ﬁndings
(Schmahl et al., 2004). Unlike the case for Fgfr2mutants, XY Fgf9 /
gonads heterozygous for Wnt4 (Wnt4þ /) did not show rescue and
instead resembled the Fgf9 mutant alone. However, in XY Fgf9 /;
Wnt4 / gonads, we observed a complete rescue of the Fgf9 / sex
reversal phenotype, with possibly a slight reduction in testis size
(Fig. 3E). All seven XY Fgf9/Wnt4 double mutant gonads collected
were phenotypically male.
Somatic cell fate was properly adopted and cellular organization was
normal in XY Fgf9/Wnt4 double mutant gonads
All somatic cell types examined were properly speciﬁed in XY
Fgf9 /; Wnt4 / gonads (Fig. 4). First, we checked for thepresence of maturing Sertoli cells in testis cords, which were
immunostained with antibodies against SOX9 and AMH. The XX
controls lacked Sertoli cells labeled with SOX9 and AMH (Fig. 4A).
Sertoli cells were present in XY controls and Wnt4 mutants
(Fig. 4B and C). XY Fgf9 mutants resembled ovaries. Occasional
SOX9-positive cells were observed in the XY Fgf9 mutant gonads
(which were rarely seen in XX controls), but they were not AMH
positive as Sertoli cells normally are at this stage (Fig. 4D). In
contrast, the XY Fgf9 /; Wnt4 / gonads had testis cords with
SOX9- and AMH-positive Sertoli cells similar to control XY gonads
(Fig. 4E).
We also examined whether germ cells, labeled by CDH1
(E-cadherin), were clustered inside testis cords, and whether
Leydig cells, expressing the steroidogenic enzyme 3b-HSD, were
present outside of the testis cords (in the interstitium). The germ
cells in the XX control were not clustered into testis cords and
Leydig cells labeled with 3b-HSD were not present (Fig. 4F). In
contrast, in XY controls and Wnt4 mutants, germ cells were
clustered inside testis cords and Leydig cells were found in the
interstitium (Fig. 4G and H). XY Fgf9mutants resembled ovaries in
that germ cells were not clustered into testis cords and Leydig
cells were absent (Fig. 4I). However, deletion of Wnt4 in an Fgf9
S.A. Jameson et al. / Developmental Biology 370 (2012) 24–32 29mutant rescued both the organization of germ cells in cords and
the development of Leydig cells (Fig. 4J). In 1 of 4 double mutant
XY samples, there was reduced CDH1 staining (data not shown),
but based on nuclear morphology, germ cells were still present in
testis cords. Similarly, we observed a range of 3b-HSD staining
intensity in XY Wnt4 mutants and Fgf9/Wnt4 double mutants
(data not shown). Nevertheless, cells positive for 3b-HSD were
observed in all samples of these genotypes examined. Thus, all
aspects of somatic male development that we examined were
rescued in XY Fgf9 / mice by deletion of Wnt4. We observed no
sex reversed regions in these double mutant gonads (Fig. S2).
Male germ cell fate was properly adopted in XY Fgf9/Wnt4 double
mutant gonads
Fgf9 was reported to inhibit the entry of the germ cells into
meiosis (Barrios et al., 2010; Bowles et al., 2010). However, Fgf9 is
not required to prevent the entry of the germ cells into meiosis in
the absence of Wnt4. Nuclear SCP3 labels meiotic germ cells,
which are present in XX controls and absent from both XY
controls and XY Wnt4 mutants (Fig. 5A–C). The germ cells in
Fgf9 mutants were in meiosis (Fig. 5D) (Bowles et al., 2010),
although there was somewhat variable loss of germ cells in these
mutants (Fig. S2). However, when both Fgf9 and Wnt4 were
deleted, SCP3 was absent (Fig. 5E). Together, these results showed
that both the somatic and germ cell sex reversal phenotype of the
XY Fgf9 mutants was rescued by deleting Wnt4.
Because the germ cells in the XY Fgf9/Wnt4 double mutants
were not meiotic, we investigated whether they were positive for
a male germ cell marker at this stage. DNMT3L is a DNA
methyltransferase implicated in genomic imprinting. The expres-
sion of DNMT3L is speciﬁc to male germ cells from E14.5 to E18.5,
while in the female, expression begins only after birth (Bourc’his
and Bestor, 2004; Bourc’his et al., 2001; Sakai et al., 2004)
DNMT3L was absent in E16.5 XX gonads but present in the XY
controls (Fig. 5F and G) and in XY Wnt4 single mutants (Fig. 5H).
In sex reversed Fgf9 mutant XY gonads (Fig. 5I), no DNMT3L
positive germ cells were observed, while in the Fgf9 /; Wnt4 /
double mutants (Fig. 5J), germ cells were positive for DNMT3LFig. 5. Germ cells in the XY Fgf9/Wnt4 double mutants adopt the male fate. Immunostainin
meiosis marker SCP3 (red) that is nuclear in meiotic germ cells. Meiotic germ cells we
and present in sex reversed XY Fgf9 mutants (D). The germ cells in the Fgf9/Wnt4 dou
of 12 images over approximately 12 mm using a 40X objective. Scale bar¼100 mm. n
DNMT3L (red). In E16.5 gonads, DNMT3L is absent in XX control gonads (F), but p
mutants (I) do not express DNMT3L, consistent with their failure to enter the male p
suggesting rescue of the male pathway (J). Images are maximum intensity projections of
of each genotype. For XY Wnt4 ((C) and (H)) and Fgf9 ((D) and (I)) single mutants, the o
and ‘‘Wnt4þ ’’).staining, indicating they had adopted the male fate. We also
found that the germ cells properly entered mitotic arrest in the
XY Fgf9 /; Wnt4 / double mutants (Fig. S3), further conﬁrming
that the germ cells have properly adopted the male fate in the
Fgf9/Wnt4 double mutant males.The partial sex reversal phenotype of XX Wnt4 mutants is not rescued
by deletion of Fgf9
Unlike XX controls, XX Wnt4 / gonads develop features
normally seen only in XY gonads: a coelomic vessel and steroido-
genic cells (Jeays-Ward et al., 2003; Vainio et al., 1999) (Fig. 6A–D).
Previous work exploring the antagonism between FGF9 and Wnt4
signaling showed that FGF9 was elevated in XX Wnt4 mutants
(Kim et al., 2006). It has also been shown previously that FGF9 can
induce migration of mesonephric endothelial cells into the XX
gonad (Colvin et al., 2001). Thus, we hypothesized that elevation of
FGF9 in XXWnt4 / gonads might be responsible for development
of the testis-like characteristics in these mutants. To investigate
this possibility, we examined XX Fgf9 /; Wnt4 / gonads. In
E16.5–E17.5 XX wild type gonads, neither the coelomic vessel nor
steroidogenic cells are detected (Fig. 6A and B). However, in Wnt4
mutants, we identiﬁed the coelomic vessel as well as ectopic
steroidogenic cells (Fig. 6C and D). Neither the steroidogenic cells
nor the ectopic vessel were apparent in the XX Fgf9 / gonads
(Fig. 6E and F). However, the XX Fgf9 /;Wnt4 / mice developed
a coelomic vessel and steroidogenic cells similar to the Wnt4
mutants (Fig. 6G and H). The number of steroidogenic cells and
the appearance of the ectopic vessel were variable in both XX
Wnt4 / and Fgf9 /; Wnt4 / gonads (Fig. S4), but both were
present in three gonads of each genotype analyzed. The presence of
an ectopic vessel and steroidogenic cells in the absence of Fgf9
indicates that Fgf signaling is not necessary for coelomic vessel
formation or steroidogenesis in vivo. In further support of this
conclusion, deleting Fgfr2 in endothelial cells had no effect on
coelomic vessel formation in XY gonads (Fig. S5). These results
show that development of the male-like characteristics in XX
Wnt4/ gonads does not require Fgf9.g of E16.5–E17.5 gonads. DNA is shown in blue. ((A)–(E)) Gonads labeled with the
re present in XX controls (A), absent in XY controls (B) and XY Wnt4 mutants (C),
ble mutants were not in meiosis (E). Images are maximum intensity projections
¼3 of each genotype. ((F)–(J)) Gonads labeled with the male germ cell marker,
resent in XY controls (G) and XY Wnt4 single mutants (H). Germ cells in Fgf9
athway. However, DNMT3L expression is detected in Fgf9/Wnt4 double mutants,
6 images over approximately 6 mm using a 40X objective. Scale bar¼100 mm. n¼3
ther locus was either homozygous wild type or heterozygous (designated ‘‘Fgf9þ ’’
Fig. 6. Deleting Fgf9 did not rescue the phenotypes of XX Wnt4 mutants. DNA is shown in blue. ((A), (C), (E) and (G)) PECAM1 (green) labels both the endothelial cells and the
germ cells, but with varying intensity in the germ cells at E16.5–E17.5. ((B), (D), (F) and (H)) E16.5–E17.5 gonads labeled with the steroidogenic marker 3b-HSD (red).
Unlike XX control ovaries ((A) and (B)), XXWnt4mutants developed an ectopic coelomic vessel ((C), arrows) and steroidogenic cells (D). ((E) and (F)) In the presence of one
or more functional copies of Wnt4, Fgf9mutants did not develop this ectopic vessel or steroidogenic cells. However, both the ectopic vessel ((G), arrows) and steroidogenic
cells (H) were present in the XXWnt4/Fgf9 double mutants. The images shown are maximum intensity projections of 5 images over approximately 10 mm ((A), (C), (E) and
(G)) or 10 images over approximately 30 mm ((B), (D), (F) and (H)) taken using a 20X objective. For XX Wnt4 ((C) and (D)) and Fgf9 ((E) and (F)) single mutants, the other
locus was homozygous wild type or heterozygous (designated ‘‘Fgf9þ ’’ and ‘‘Wnt4þ ’’). Scale bar¼100 mm. n¼3 of each genotype.
Fig. 7. Model of sex determination. A model of the genetic interactions during early
gonad development. SRY up-regulates SOX9 in XY gonads, and SOX9 becomes self-
regulating (Sekido and Lovell-Badge, 2008). SOX9 up-regulates Fgf9 (Kim et al.,
2006) to repress Wnt4, and possibly also reinforce its own expression. A failure to
repress Wnt4 (in Fgf9 or Fgfr2 mutants) results in repression of SOX9 by Wnt4
signaling and loss of male development.
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Mammalian sex determination depends on the fate decision
that occurs in the supporting cell lineage of the gonad. We
recently demonstrated that both XX and XY supporting cells are
‘‘primed’’ to adopt the male and female fate. During the bipoten-
tial stage, supporting cells isolated from XX and XY gonads have a
common transcriptome characterized by the expression of tran-
scripts associated with both the male and female fates, but genes
associated with the female fate are over-represented (Jameson
et al., 2012). This results in the repression of many female genes
when these cells adopt the male fate. This is consistent with
antagonism between the male and female programs reported by
multiple laboratories (Bradford et al., 2009; Chassot et al., 2008;
Kent et al., 1996; Kim et al., 2006; Morais da Silva et al., 1996;
Munger et al., 2009; Swain et al., 1998; Vainio et al., 1999).
However, the functional importance of repression of the female
program to the adoption of the male fate had not been directly
tested. Here, we provide evidence that the fate commitment of
the XY supporting cells requires repression of the female-asso-
ciated gene,Wnt4. This ﬁnding is in accord with predictions in the
theoretical sex determination literature (Koopman, 1999;
McElreavey et al., 1993; Sekido and Lovell-Badge, 2009).
In XY gonads, expression of the Y-linked gene Sry diverts the
fate of the supporting cells toward Sertoli cell differentiation
(Fig. 7). SRY acts directly to up-regulate Sox9 transcription by
binding to the TESCO element in the Sox9 promoter (Sekido and
Lovell-Badge, 2008). Once activated, SOX9 binds its own promoter
to maintain expression (Sekido and Lovell-Badge, 2008). However,
continued SOX9 expression is also critically dependent on the
extracellular signaling molecule Fgf9 and its receptor Fgfr2. In the
absence of Fgf signaling in XY gonads, SOX9 expression is lost,
Wnt4 is elevated, and the gonad switches to the female fate (Kim
et al., 2007, 2006). We proposed that FGF9 and SOX9 create a
positive feed-forward loop to stabilize SOX9 and repress Wnt4
(Kim et al., 2006). However, our present results suggest that the
primary role of Fgf9 is the repression of female genes (including
Wnt4) that would otherwise antagonize male development
(Fig. 7).
Wnt4 is initially expressed in both XX and XY gonads and
positively reinforces its own expression (Liu et al., 2009; Maatouk
et al., 2008; Nef et al., 2005; Vainio et al., 1999) (Fig. 7). However,
its expression declines by E11.5 in XY gonads, soon after Sry/Sox9activation and coincident with a pulse of Fgf9 expression (Nef
et al., 2005; Vainio et al., 1999). In XY Fgf9 / gonads, Wnt4 and
other female genes showed some derepression by E11.75,
preceding SOX9 protein loss (although it was generally not
statistically signiﬁcant until E12.5) (Kim et al., 2006). Wnt4 and
its downstream effector b-catenin are known to repress SOX9 in
the gonad (Chang et al., 2008; Kim et al., 2006; Maatouk et al.,
2008). This, coupled with the ability of Wnt4 deletion to rescue
both the Fgfr2 and Fgf9 male-to-female sex reversal phenotypes,
suggests that the primary function of Fgf signaling is to repress
Wnt4.
We cannot exclude the possibility that FGF9 has some direct
role in activating Sox9 expression in addition to repressing female
transcripts. There is some evidence suggesting that FGF9 can up-
regulate Sox9 independent of Wnt4 (Hiramatsu et al., 2010), and
we detected a small difference in Sox9 expression in XY Fgf9
mutant gonads at all time points (although it is not statistically
signiﬁcant before E12.5). Nonetheless, our results demonstrate
that when Wnt4 and other genes associated with the female
pathway are downregualted, the level of SOX9 in the XY Fgf9
mutants is sufﬁcient to maintain male development.
Interestingly, Sox9 transcript is not repressed to female levels
in XY Fgf9 mutant gonads at E12.5, despite the fact that the
protein is absent (Kim et al., 2006). This ﬁnding is reminiscent of
the role of Wnt signaling in chondrocytes where b-catenin
represses SOX9 at the protein level through a physical interaction,
leading to mutual protein degradation (Akiyama et al., 2004). Wnt
signaling may also repress Sox9 at the transcriptional level based
on recent data (Bernard et al., 2011), but our results suggest that
transcriptional repression is unlikely to be its sole function.
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genous female levels is sufﬁcient to block testis development,
indicating that active repression of the female program is
required for male development. This is consistent with previous
data illustrating the ability of over-expressed female genes to
block male development. In humans a duplication containing
Wnt4 and Rspo1 disrupted XY male development (Jordan et al.,
2001; Tevosian and Manuylov, 2008). In the mouse, constitutive
activation of b-catenin in XY gonads caused sex reversal (Chang
et al., 2008; Maatouk et al., 2008), although the over-expression
of Wnt4 or Rspo1 alone was not sufﬁcient to induce male to
female sex reversal in mice (Buscara et al., 2009; Jeays-Ward
et al., 2003; Jordan et al., 2003). Over-expression of multiple
female genes, as occurs in the XY Fgf9 mutants, may be required
to achieve the level of b-catenin signaling to repress male
development in mice. This is consistent with our ﬁnding that
deletion of only one of these factors (Wnt4) is sufﬁcient to prevent
the male-to-female sex reversal of XY Fgf9 mutants.
The differences between the human and mouse may reﬂect the
relative strength of the male and female programs in different
species. In humans, mutations in RSPO1 alone can result in
female-to-male sex reversal in the absence of SRY (Parma et al.,
2006). However, full male development does not occur in XX
mouse gonads if any one of the Wnt pathway components (Wnt4,
Rspo1, or b-catenin) is deleted (Chassot et al., 2008; Jeays-Ward
et al., 2003; Liu et al., 2009; Manuylov et al., 2008; Tomizuka
et al., 2008; Vainio et al., 1999). Although SOX9 was detected
transiently in XX gonads mutant for Wnt4 alone and the female
program was disrupted (Coveney et al., 2008; Kim et al., 2006;
Vainio et al., 1999), the full male program was not established.
This may indicate that the male program in the mouse needs
more reinforcement (from SRY) to become established than the
male program in humans.
There is an asymmetry in the relationship between Fgf9 and
Wnt4. Since the Fgf9 phenotypes were the result of Wnt4 derepres-
sion, we investigated whether the XX Wnt4 mutant phenotypes
were caused by derepression of Fgf9. We show that this is not the
case: the XX Wnt4 mutant phenotypes were not rescued by the
deletion of Fgf9. Even though exogenous FGF9 can induce migration
of mesonephric endothelial cells into the XX gonad (Colvin et al.,
2001), endogenous FGF9 does not appear to have this function
in vivo. It may be that exogenous FGF9 induces endothelial migra-
tion through the repression of Wnt4. The ﬁnding that Fgf9 loss does
not affect coelomic vessel formation in the Wnt4 mutants is also
consistent with previous work showing that Wnt4 results in vessel
formation by repressing inhibin beta B (Yao et al., 2006).
These results also bring into question the role of Fgf9 in the
development of other cell types in the XY gonad. Both Sertoli cells
and Leydig cells appeared to develop normally in double mutants.
Fgf9 has been reported to promote male germ cell development
and repress the female meiotic program (Barrios et al., 2010;
Bowles et al., 2010). However, while Fgf9 may reinforce the male
germ cell fate, we show that Fgf9 is not required to block meiosis
or induce mitotic arrest in the context of normal male
development.
The primary role of Fgf9 appears to be coupling the activation
of the male program to the repression of the female program,
which would otherwise repress the male program. This double
negative mechanism is a common feature of many developmental
systems (Bracken et al., 2008; Davidson et al., 2002; Ferrell, 2002;
Johnston et al., 2005; Revilla-i-Domingo et al., 2007). Previous
work in the gonad characterized these antagonistic programs and
the repression of the female program in the XY gonad (Bradford
et al., 2009; Chassot et al., 2008; Jameson et al., 2012; Kent et al.,
1996; Kim et al., 2006; Morais da Silva et al., 1996; Munger et al.,
2009; Swain et al., 1998; Vainio et al., 1999). Here, we show thatthe repression of the female program is required for male
development.Conclusion
Fgf9 is critical to a repression program in the XY gonad that
blocks female gene expression that would otherwise antagonize
male development. Using Fgfr2/Wnt4 and Fgf9/Wnt4 double
mutant mice, we show that Fgf signaling promotes male sex
determination by repressing the female-promoting genes. If the
male program is unable to repress Wnt4 due to loss of either Fgf9
or Fgfr2, male development is aborted. Thus, the decision to adopt
the male fate is based not only on whether male genes, such as
Sox9, are expressed, but also on the repression of female genes,
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